ONCY:NASDAQ
Oncolytics Biotech Inc
၀.၄၈ US$
arrow_upward
+၁.၅၈%(+၀.၀၀၇၅) 1D
အောက် ၁၃, GMT-၄ ၁၅:၀၁:၃၅ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ONCY...
Open
၀.၄၉ US$
High
၀.၅၀ US$
Low
၀.၄၅ US$
Mkt. cap
၆.၃၅ ကုဋေ
Avg. vol.
၁.၁၆ သန်း
Volume
၃.၄၉ သန်း
52-wk high
၁.၃၂ US$
52-wk low
၀.၄၄ US$
Beta
၁.၁၅
Shares outstanding
၁၂.၇၅ ကုဋေ
No. of employees
၂၉
Open
၀.၄၉ US$
High
၀.၅၀ US$
Low
၀.၄၅ US$
Mkt. cap
၆.၃၅ ကုဋေ
Avg. vol.
၁.၁၆ သန်း
Volume
၃.၄၉ သန်း
52-wk high
၁.၃၂ US$
52-wk low
၀.၄၄ US$
Beta
၁.၁၅
Shares outstanding
၁၂.၇၅ ကုဋေ
No. of employees
၂၉
News stories
From web sources and news partners
Yahoo! Finance Canada
·
ပြီးခဲ့သည့် ၁ နာရီ
Stocks in play: Oncolytics Biotech Inc
TipRanks
·
ပြီးခဲ့သည့် ၂၂ နာရီ
Oncolytics Biotech Extends Pelareorep Patent Protection Into Late 2040s
Stock Titan
·
ပြီးခဲ့သည့် ၂၂ နာရီ
Patent protection for Oncolytics’ cancer therapy could extend into the late 2040s.
Profile
Oncolytics Biotech Inc. is a biotech company headquartered in San Diego, California, that is developing an intravenously delivered immuno-oncolytic virus called pelareorep for the treatment of solid tumors and hematological malignancies. Pelareorep is a non-pathogenic, proprietary isolate of the unmodified reovirus that induces selective tumor lysis and promotes an inflamed tumor phenotype through innate and adaptive immune responses. Wikipedia
About Oncolytics Biotech Inc
CEO-
Employees၂၉
Founded၁၉၉၈
Headquartersကယ်လ်ဂရီမြို့, အယ်လဗားတားပြည်နယ်, ကနေဒါ
Sector-
Websiteoncolyticsbiotech.com